Lastly, we identify the BMP signaling pathway as a potential effective therapeutic strategy to treat ACVR1 R206H mutant DIPGs as exogenous Noggin expression at tumor initiation or treatment with LDN212854 significantly increases tumor latency and prolongs survival. This evidence concerns the gene NOG and neoplasm.